Parkinson S Disease Articles & Analysis: Older
26 articles found
The experimental setup of the cardiopulmonary portion involved the implantation of emka easyTEL-S-ETA telemetry sensors for electrocardiography (ECG) recordings, enabling the monitoring of heart rate in freely moving mice expressing ChR2 (a light-sensitive protein) in the PPN or vlPAG (ventrolateral periaqueductal gray). emka & SCIREQ whole-body plethysmography (WBP), ...
People living with frontotemporal dementia, or FTD, are commonly misdiagnosed with psychiatric disorders or Alzheimer’s disease and other causes of dementia, such as Parkinson’s disease and vascular dementia. While frontotemporal dementia and Alzheimer’s ...
, this type of research helps medical researchers understand people’s health and how we can make treatments better for everyone. But health research isn’t possible without the contributions of research participants. ...
In PhysioSensing Balance software there is a similar test namedUnilateral Stance, which allows the assessment of the patient’s postural control with left and right foot raised, alternately, enhancing the standard one leg test with objective quantification of sway. ...
Clinical trials are often designed with the participant’s everyday life in mind – trying to gather as much clinically-relevant data in a controlled manner as possible while allowing individuals to live their regular lives. ...
ByAiCure
Alzheimer’s and Parkinson’s disease are both neurological diseases that cause progressive damage to the brain, resulting in a decline in neurocognitive function. While Parkinson’s disease is known for affecting movement and function and ...
Parkinson’s disease is a progressive neurodegenerative disease that is most commonly known for affecting movement. ...
It quantifies the ability to intentionally displace the center of gravity to the patient’s stability limits without losing balance. This protocol provides information regarding voluntary motor control, which also helps screening fall risk in elderly people [1]. ...
Australian researchers have recently solved a multi-year mystery about Parkinson's disease. They solved the structure of a key protein that is expected to rapidly treat this incurable disease. The findings appear in Nature. For the first time, the researchers took a "live" shot of a protein called PINK1. The findings explain how this protein is activated in cells, thereby initiating the ...
Mean COP Velocity:Distance travelled by center of pressure divided by test time (mm/s or °/s). COP Ellipse Area:Area of the prediction ellipse with 95% of the COP values (mm²). ...
Several conditions like stroke, Parkinson’s disease, multiple sclerosis, vestibular dysfunctions, knee and foot lesions, among many others will affect balance. ...
Today, there are only a few therapies approved to treat COVID-19, but while novel therapies can take decades and billions of dollars to develop, are there opportunities to repurpose existing drugs for new therapies? Our latest whitepaper showcases how CAS Knowledge Graphs reveal new connections and insights that identify drugs to potentially repurpose. Drug repurposing is critical for faster ...
“After years of research, we believe that A-I can provide the path to relief for millions of people suffering from Neurodegeneration such as Alzheimer’s, Parkinson’s and other neuro-brain disorders and mental ...
However, if you notice that an overactive bladder impacts the quality of life that you’re living, it’s time for you to seek treatment. What Are the Symptoms of an Overactive Bladder? ...
Deep brain stimulation (DBS) is used to treat multiple neuropsychiatric disorders, including Parkinson’s disease (PD). Despite widespread clinical use, its therapeutic mechanisms are unknown. ...
Alcyone Lifesciences is a medical technology company based out of Lowell, MA, which specializes in central nervous system (CNS) drug delivery platforms for targeted infusions of the brain or spinal cord. Their Thecaflex DRx System was recently awarded Breakthrough Device designation by the FDA, for spinal infusion of therapeutic medications. Medgadget had the opportunity to speak with Alcyone ...
Sacks described his approach to his work: Although it's up to me as a neurologist to diagnose the disease and to think in therapeutic terms, I always want to address the person as much as the disease, and I'm very glad my own doctor feels similarly. ...
The two new treatment strategies described, levodopa/carbidopa intestinal gel and levodopa/carbidopa microtablets, for advanced Parkinson's disease, have been developed in collaborative research within departments at Uppsala University. With this historical approach, reference priority is given to reports considered to be of special importance for this more than ...
PDx’s proprietary gene discovery platform has revealed an NUBPL mutation that is believed to be linked to Parkinson’s disease. ...
Abstract During its almost half-century of use for treating Parkinson's disease, levodopa therapy has permitted most patients to reverse much of this disorder's symptomatology. However, the full range of its therapeutic properties is not completely understood, as levodopa is showing itself to be more than just a metabolic intermediate for dopamine synthesis. Improving the constancy of drug ...